Humana 2028 increased by 21.4% to $17.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 50.0%, from $34.00M to $17.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher values indicate a larger base of acquired intangible assets that will be expensed in that specific year, potentially impacting future net income.
The projected amortization expense for finite-lived intangible assets specifically for the fiscal year 2028. This repres...
Standard disclosure for companies with significant M&A activity and purchase price allocations.
other_finite_lived_intangible_assets_amortization_expens_398565| Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $54.00M | $58.00M | $43.00M | $43.00M | $43.00M | $34.00M | $34.00M | $14.00M | $17.00M |
| QoQ Change | — | +7.4% | -25.9% | +0.0% | +0.0% | -20.9% | +0.0% | -58.8% | +21.4% |
| YoY Change | — | — | -20.4% | -25.9% | — | -20.9% | -20.9% | -67.4% | -50.0% |